» Articles » PMID: 35890278

Biosynthetic Nanobubble-Mediated CRISPR/Cas9 Gene Editing of Cdh2 Inhibits Breast Cancer Metastasis

Overview
Journal Pharmaceutics
Publisher MDPI
Date 2022 Jul 27
PMID 35890278
Authors
Affiliations
Soon will be listed here.
Abstract

The epithelial-mesenchymal transition (EMT), a process in which epithelial cells undergo a series of biochemical changes to acquire a mesenchymal phenotype, has been linked to tumor metastasis. Here, we present a novel strategy for knocking out the EMT-related Cdh2 gene, which encodes N-cadherin through CRISPR/Cas9-mediated gene editing by an ultrasound combined with biosynthetic nanobubbles (Gas Vesicles, GVs). Polyethyleneimine were employed as a gene delivery vector to deliver sgRNA into 4T1 cells that stably express the Cas9 protein, resulting in the stable Cdh2 gene- knockout cell lines. The Western blotting assay confirmed the absence of an N-cadherin protein in these Cdh2 gene-knockout 4T1 cell lines. Significantly reduced tumor cell migration was observed in the Cdh2 gene-knockout 4T1 cells in comparison with the wild-type cells. Our study demonstrated that an ultrasound combined with GVs could effectively mediate CRISPR/Cas9 gene editing of a Cdh2 gene to inhibit tumor invasion and metastasis.

Citing Articles

Emerging Gene-editing nano-therapeutics for Cancer.

Nujoom N, Koyakutty M, Biswas L, Rajkumar T, Nair S Heliyon. 2024; 10(21):e39323.

PMID: 39524822 PMC: 11550658. DOI: 10.1016/j.heliyon.2024.e39323.


Applications of CRISPR Technology to Breast Cancer and Triple Negative Breast Cancer Research.

Pont M, Marques M, Sorolla M, Parisi E, Urdanibia I, Morales S Cancers (Basel). 2023; 15(17).

PMID: 37686639 PMC: 10486929. DOI: 10.3390/cancers15174364.


Nanoparticles in Medicine: Current Status in Cancer Treatment.

Pavelic K, Kraljevic Pavelic S, Bulog A, Agaj A, Rojnic B, colic M Int J Mol Sci. 2023; 24(16).

PMID: 37629007 PMC: 10454499. DOI: 10.3390/ijms241612827.


The CRISPR/Cas9 System Delivered by Extracellular Vesicles.

Zhu X, Gao M, Yang Y, Li W, Bao J, Li Y Pharmaceutics. 2023; 15(3).

PMID: 36986843 PMC: 10053467. DOI: 10.3390/pharmaceutics15030984.

References
1.
Shen Y, Shen Y, Li J, Ding F, Wang Y . Polyethyleneimine-anchored liposomes as scavengers for improving the efficiency of protein-bound uremic toxin clearance during dialysis. J Biomed Mater Res A. 2021; 110(4):976-983. DOI: 10.1002/jbm.a.37346. View

2.
Walker A, Frei R, Lawson K . The cytoplasmic domain of N-cadherin modulates MMP‑9 induction in oral squamous carcinoma cells. Int J Oncol. 2014; 45(4):1699-706. PMC: 4151807. DOI: 10.3892/ijo.2014.2549. View

3.
Rogers M, Rush R . Non-viral gene therapy for neurological diseases, with an emphasis on targeted gene delivery. J Control Release. 2011; 157(2):183-9. DOI: 10.1016/j.jconrel.2011.08.026. View

4.
Moretti A, Fonteyne L, Giesert F, Hoppmann P, Meier A, Bozoglu T . Somatic gene editing ameliorates skeletal and cardiac muscle failure in pig and human models of Duchenne muscular dystrophy. Nat Med. 2020; 26(2):207-214. PMC: 7212064. DOI: 10.1038/s41591-019-0738-2. View

5.
Wang Y, Zhou Q, Cao S, Hu B, Deng Q, Jiang N . Efficient gene therapy with a combination of ultrasound‑targeted microbubble destruction and PEI/DNA/NLS complexes. Mol Med Rep. 2017; 16(5):7685-7691. DOI: 10.3892/mmr.2017.7510. View